MARKET COMPOSITE
ILMN - Illumina Inc7:59:55 PM 4/25/2024
Price
$121.02
-1.86 (-1.51%)
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. Illumina's technology had purportedly by 2014 reduced the cost of sequencing a human genome to US$1,000, down from a price of $1 million in 2007. Customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue1.1B+0%
Gross Profit673MM-2%
Cost Of Revenue449MM+3%
Operating Income-163MM-78%
Operating Expenses836MM-42%
Net Income-176MM-77%
R&D340MM+8%
G&A481MM+59%
Interest Expense19MM-
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news